179 related articles for article (PubMed ID: 37152049)
1. Long-term and real-life incidence of cancer therapy-related cardiovascular toxicity in patients with breast cancer: a Swedish cohort study.
Hubbert L; Mallios P; Karlström P; Papakonstantinou A; Bergh J; Hedayati E
Front Oncol; 2023; 13():1095251. PubMed ID: 37152049
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular adverse events and prognosis in patients with haematologic malignancies and breast cancer receiving anticancer agents: Kurume-CREO Registry insights.
Shibata T; Nohara S; Morikawa N; Shibao K; Ito S; Shibata R; Toh U; Nagafuji K; Fukami K; Fukumoto Y
Eur J Prev Cardiol; 2023 Dec; 30(18):1941-1949. PubMed ID: 37352112
[TBL] [Abstract][Full Text] [Related]
3. High neutrophil-to-lymphocyte ratio is associated with cancer therapy-related cardiovascular toxicity in high-risk cancer patients under immune checkpoint inhibitor therapy.
Haj-Yehia E; Mincu RI; Korste S; Lampe L; Margraf SM; Michel L; Mahabadi AA; Ferdinandy P; Rassaf T; Totzeck M
Clin Res Cardiol; 2024 Feb; 113(2):301-312. PubMed ID: 37955712
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular outcomes in breast cancer survivors: a systematic review and meta-analysis.
Galimzhanov A; Istanbuly S; Tun HN; Ozbay B; Alasnag M; Ky B; Lyon AR; Kayikcioglu M; Tenekecioglu E; Panagioti M; Kontopantelis E; Abdel-Qadir H; Mamas MA
Eur J Prev Cardiol; 2023 Dec; 30(18):2018-2031. PubMed ID: 37499186
[TBL] [Abstract][Full Text] [Related]
5. Risk of heart failure after systemic treatment for early breast cancer: results of a cohort study.
Jacobse JN; Schaapveld M; Boekel NB; Hooning MJ; Jager A; Baaijens MHA; Hauptmann M; Russell NS; Rutgers EJT; Aleman BMP; Sonke GS; van Leeuwen FE
Breast Cancer Res Treat; 2021 Jan; 185(1):205-214. PubMed ID: 32964358
[TBL] [Abstract][Full Text] [Related]
6. Outcome and presentation of heart failure in breast cancer patients: findings from a Swedish register-based study.
Hedayati E; Papakonstantinou A; Gernaat SAM; Altena R; Brand JS; Alfredsson J; Bhoo-Pathy N; Herrmann J; Linde C; Dahlstrom U; Bergh J; Hubbert L
Eur Heart J Qual Care Clin Outcomes; 2020 Apr; 6(2):147-155. PubMed ID: 31328233
[TBL] [Abstract][Full Text] [Related]
7. Association of Early-Stage Breast Cancer and Subsequent Chemotherapy With Risk of Atrial Fibrillation.
Abdel-Qadir H; Thavendiranathan P; Fung K; Amir E; Austin PC; Anderson GS; Lee DS
JAMA Netw Open; 2019 Sep; 2(9):e1911838. PubMed ID: 31539076
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular Disease in Patients With Breast Cancer Treated in the Modern Era.
Murphy AC; Koshy AN; Farouque O; Yeo B; Roccisano L; Octavia Y; Yudi MB
Heart Lung Circ; 2024 May; 33(5):648-656. PubMed ID: 37574416
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular toxicity in breast cancer patients - contributors and role of cardioprotective drugs.
Martins Carvalho M; Alves Pinto R; Proença T; Costa I; Tavares N; Paiva M; Sousa C; Macedo F
Monaldi Arch Chest Dis; 2023 Mar; 93(4):. PubMed ID: 37009760
[TBL] [Abstract][Full Text] [Related]
10. Lifestyle and Cardiovascular Risk Factors Associated With Heart Failure Subtypes in Postmenopausal Breast Cancer Survivors.
Reding KW; Cheng RK; Vasbinder A; Ray RM; Barac A; Eaton CB; Saquib N; Shadyab AH; Simon MS; Langford D; Branch M; Caan B; Anderson G
JACC CardioOncol; 2022 Mar; 4(1):53-65. PubMed ID: 35492810
[TBL] [Abstract][Full Text] [Related]
11. Association of Anthracycline With Heart Failure in Patients Treated for Breast Cancer or Lymphoma, 1985-2010.
Larsen CM; Garcia Arango M; Dasari H; Arciniegas Calle M; Adjei E; Rico Mesa J; Scott CG; Thompson CA; Cerhan JR; Haddad TC; Goetz MP; Herrmann J; Villarraga HR
JAMA Netw Open; 2023 Feb; 6(2):e2254669. PubMed ID: 36735254
[TBL] [Abstract][Full Text] [Related]
12. Long-term cardiovascular disease risk after anthracycline and trastuzumab treatments in U.S. breast cancer survivors.
Vo JB; Ramin C; Veiga LHS; Brandt C; Curtis RE; Bodelon C; Barac A; Roger VL; Feigelson HS; Buist DSM; Bowles EJA; Gierach GL; Berrington de González A
J Natl Cancer Inst; 2024 May; ():. PubMed ID: 38718210
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular disease after Hodgkin lymphoma treatment: 40-year disease risk.
van Nimwegen FA; Schaapveld M; Janus CP; Krol AD; Petersen EJ; Raemaekers JM; Kok WE; Aleman BM; van Leeuwen FE
JAMA Intern Med; 2015 Jun; 175(6):1007-17. PubMed ID: 25915855
[TBL] [Abstract][Full Text] [Related]
14. Risk of Cardiovascular Disease in Women With and Without Breast Cancer: The Pathways Heart Study.
Greenlee H; Iribarren C; Rana JS; Cheng R; Nguyen-Huynh M; Rillamas-Sun E; Shi Z; Laurent CA; Lee VS; Roh JM; Santiago-Torres M; Shen H; Hershman DL; Kushi LH; Neugebauer R; Kwan ML
J Clin Oncol; 2022 May; 40(15):1647-1658. PubMed ID: 35385342
[TBL] [Abstract][Full Text] [Related]
15. Breast cancer and incident cardiovascular events: A systematic analysis at the nationwide level.
Gue YX; Bisson A; Bodin A; Herbert J; Lip GYH; Fauchier L
Eur J Clin Invest; 2022 Jun; 52(6):e13754. PubMed ID: 35113450
[TBL] [Abstract][Full Text] [Related]
16. Risk of Cardiovascular Disease Associated with a Restless Legs Syndrome Diagnosis in a Retrospective Cohort Study from Kaiser Permanente Northern California.
Van Den Eeden SK; Albers KB; Davidson JE; Kushida CA; Leimpeter AD; Nelson LM; Popat R; Tanner CM; Bibeau K; Quesenberry CP
Sleep; 2015 Jul; 38(7):1009-15. PubMed ID: 26083613
[TBL] [Abstract][Full Text] [Related]
17. Mortality After Major Cardiovascular Events in Survivors of Childhood Cancer.
Bottinor W; Im C; Doody DR; Armenian SH; Arynchyn A; Hong B; Howell RM; Jacobs DR; Ness KK; Oeffinger KC; Reiner AP; Armstrong GT; Yasui Y; Chow EJ
J Am Coll Cardiol; 2024 Feb; 83(8):827-838. PubMed ID: 38383098
[TBL] [Abstract][Full Text] [Related]
18. Mortality and Major Adverse Cardiac Events in Patients With Breast Cancer Receiving Radiotherapy: The First Decade.
Jacobs JEJ; L'Hoyes W; Lauwens L; Yu YL; Brusselmans M; Weltens C; Voigt JU; Wildiers H; Neven P; Herrmann J; Thijs L; Staessen JA; Janssens S; Van Aelst LNL
J Am Heart Assoc; 2023 Apr; 12(8):e027855. PubMed ID: 37026536
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular disease in women with breast cancer - a nationwide cohort study.
Jakobsen M; Kolodziejczyk C; Jensen MS; Poulsen PB; Khan H; Kümler T; Andersson M
BMC Cancer; 2021 Sep; 21(1):1040. PubMed ID: 34537007
[TBL] [Abstract][Full Text] [Related]
20. Temporal trends in cause-specific mortality among individuals with newly diagnosed atrial fibrillation in the Framingham Heart Study.
Kornej J; Huang Q; Preis SR; Lubitz SA; Ko D; Murabito JM; Benjamin EJ; Trinquart L
BMC Med; 2021 Jul; 19(1):170. PubMed ID: 34320976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
